Advances in hidradenitis suppurativa
Transcript: Most important issue
Aikaterini Liakou
Interview recorded Sep 2024, EADV 2024. All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speaker and is not adjusted by Medthority.
So I think that the most important issue addressed in this congress about the hidradenitis, is the new European guidelines. The new European guidelines, which are accepted this year in the European Journal, come 10 years after the last guidelines, which have been published in 2015. So for us, for the physicians it's something very important, and also for patients, of course. In the new European guidelines, there are many differences. There are, for example, there is a new clinical classification of the disease. There are two types of the disease, clinically, like the inflammatory and the non-inflammatory type. There is guidance on how to treat every stage of the disease and every type of the disease. Very, very important. And of course, there are new medications. There are new treatments which are listed in the guidelines. There are new treatments registered for the disease, which is a revolution for the physicians and for the patients.
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event
This content has been developed independently of the sponsor, UCB Biopharma SRL, which has had no editorial input into the content. EPG Health received funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.